Sponsor
This activity is jointly sponsored by Medical Learning Institute, Inc., a non-profit medical accreditation company, and Center of Excellence Media, LLC.

Target Audience
This activity was developed for pharmacy directors, P&T Committee members, managed care pharmacists, oncology pharmacists, and other key stakeholders who wish to enhance their practical insight on the health system/regional variances in the delivery of care for multiple myeloma.

Learning Objectives
At the completion of this educational activity, participants should be able to:

• Identify the intersection of epidemiologic shifts in the multiple myeloma patient population, including new diagnostic measures, staging, and achieving value-based clinical
• treatment strategies
• Discuss the treatment of the newly diagnosed patient, including review of appropriate agent selection based on recently presented clinical trials
• Describe treatment strategies in the relapsed patient, including the improvement in survival in the maintenance setting
• Examine regional/health system variations in healthcare delivery, including diagnosing, treatment, and coverage decisions for the patient with multiple myeloma

Commercial Support Acknowledgment
This activity is supported by an educational grant from Millennium Pharmaceuticals, Inc.

Instructions for Credit
There is no fee for this activity. To receive credit after reading this CE activity in its entirety, participants must complete the posttest and evaluation. The posttest and evaluation can be completed online at www.mlicme.org/p09054.html. Upon completion of the evaluation and scoring a 70% or better on the posttest, you will immediately receive your certificate online. If you do not receive a score of 70% or better on the posttest, you will be asked to take it again. Please retain a copy of the certificate for your records.

For questions regarding the accreditation of this activity, please contact Medical Learning Institute at 609-333-1693 or cgusack@mlicme.org.

Pharmacists Designation

Medical Learning Institute (MLI) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Completion of this activity provides for 2.0 contact hours (0.2 CEUs) of continuing education credit. The universal activity number for this activity is 0468-9999-10-019-H01-P.

Faculty Disclosures
Before the activity, all faculty will disclose the existence of any financial interest and/or relationship(s) they might have with the manufacturer(s) of any commercial product(s) to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers’ bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions.

The associates of Medical Learning Institute, Inc. have no financial relationships to disclose. The associates of Center of Excellence Media, LLC, have no financial relationships to disclose.

Faculty Disclosures
Gary Owens, MD, is a consultant for Amgen, Centocor-Ortho Biotech, Eli Lilly, Genentech, Novartis, and Schering Plough.

Jatin Shah, MD, is a consultant for Amgen, Celgene, and Millennium. He is also on an advisory board for Novartis.

Rusty Crawford, RPh, BCOP, has nothing to disclose.

Sin (Masha) Lam, PharmD, BCOP, has nothing to disclose.

Stephanie Taber, PharmD, BCOP, has nothing to disclose.

Disclaimer
The information provided in this CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition.

Estimated time to complete activity: 2 hours
Initial Release Date: March 30, 2010
Expiration Date: March 30, 2011

PDF: 

Download PDF